These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


141 related items for PubMed ID: 32507953

  • 21. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab.
    Brantley MA, Fang AM, King JM, Tewari A, Kymes SM, Shiels A.
    Ophthalmology; 2007 Dec; 114(12):2168-73. PubMed ID: 18054635
    [Abstract] [Full Text] [Related]

  • 22. C-reactive protein and CFH, ARMS2/HTRA1 gene variants are independently associated with risk of macular degeneration.
    Seddon JM, Gensler G, Rosner B.
    Ophthalmology; 2010 Aug; 117(8):1560-6. PubMed ID: 20346514
    [Abstract] [Full Text] [Related]

  • 23. Significance of C2/CFB variants in age-related macular degeneration and polypoidal choroidal vasculopathy in a Japanese population.
    Nakata I, Yamashiro K, Yamada R, Gotoh N, Nakanishi H, Hayashi H, Akagi-Kurashige Y, Tsujikawa A, Otani A, Saito M, Iida T, Oishi A, Matsuo K, Tajima K, Matsuda F, Yoshimura N.
    Invest Ophthalmol Vis Sci; 2012 Feb 16; 53(2):794-8. PubMed ID: 22232432
    [Abstract] [Full Text] [Related]

  • 24. Retinal Pigment Epithelial Atrophy in Neovascular Age-Related Macular Degeneration After Ranibizumab Treatment.
    Kuroda Y, Yamashiro K, Tsujikawa A, Ooto S, Tamura H, Oishi A, Nakanishi H, Miyake M, Yoshikawa M, Yoshimura N.
    Am J Ophthalmol; 2016 Jan 16; 161():94-103.e1. PubMed ID: 26432927
    [Abstract] [Full Text] [Related]

  • 25. Association between Polygenic Risk Score and One-Year Outcomes Following As-Needed Aflibercept Therapy for Exudative Age-Related Macular Degeneration.
    Shijo T, Sakurada Y, Yoneyama S, Kikushima W, Sugiyama A, Matsubara M, Fukuda Y, Mabuchi F, Kashiwagi K.
    Pharmaceuticals (Basel); 2020 Sep 20; 13(9):. PubMed ID: 32962278
    [Abstract] [Full Text] [Related]

  • 26. Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degeneration.
    Smailhodzic D, Muether PS, Chen J, Kwestro A, Zhang AY, Omar A, Van de Ven JP, Keunen JE, Kirchhof B, Hoyng CB, Klevering BJ, Koenekoop RK, Fauser S, den Hollander AI.
    Ophthalmology; 2012 Nov 20; 119(11):2304-11. PubMed ID: 22840423
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Prevalence and Genetic Characteristics of Geographic Atrophy among Elderly Japanese with Age-Related Macular Degeneration.
    Sakurada Y, Yoneyama S, Sugiyama A, Tanabe N, Kikushima W, Mabuchi F, Kume A, Kubota T, Iijima H.
    PLoS One; 2016 Nov 20; 11(2):e0149978. PubMed ID: 26918864
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clinical and genetic characteristics of pachydrusen in patients with exudative age-related macular degeneration.
    Fukuda Y, Sakurada Y, Yoneyama S, Kikushima W, Sugiyama A, Matsubara M, Tanabe N, Iijima H.
    Sci Rep; 2019 Aug 15; 9(1):11906. PubMed ID: 31417165
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Investigation of genetic base in the treatment of age-related macular degeneration.
    Gourgouli K, Gourgouli I, Tsaousis G, Spai S, Niskopoulou M, Efthimiopoulos S, Lamnissou K.
    Int Ophthalmol; 2020 Apr 15; 40(4):985-997. PubMed ID: 31916060
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration.
    Kikuchi M, Nakamura M, Ishikawa K, Suzuki T, Nishihara H, Yamakoshi T, Nishio K, Taki K, Niwa T, Hamajima N, Terasaki H.
    Ophthalmology; 2007 Sep 15; 114(9):1722-7. PubMed ID: 17400294
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.